Should intramuscular clozapine be adopted into mainstream clinical practice?

Bhattacherjee, Shaun; Young, Anthony; Ahuja, Niraj; Allen, Steven

Bhattacherjee, Shaun; Young, Anthony; Ahuja, Niraj; Allen, Steven.

Afiliação

Bhattacherjee S; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Whitehaven, UK.
Young A; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne; and Sunderland University School of Pharmacy, UK.
Ahuja N; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne; and Department of Psychiatry, Newcastle University, UK.
Allen S; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.

Br J Psychiatry ; 219(1): 357-358, 2021 07.

Article em En | MEDLINE | ID: mdl-35048857

Assuntos

Antipsicóticos; Clozapina; Transtornos Psicóticos; Esquizofrenia; Antipsicóticos/efeitos adversos; Clozapina/efeitos adversos; Humanos; Transtornos Psicóticos/tratamento farmacológico; Esquizofrenia/tratamento farmacológico

Palavras-chave

Antipsychotics; in-patient treatment; outcome studies; psychotic disorders; schizophrenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Antipsicóticos / Clozapina Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google